SPRY NASDAQ
ARS Pharmaceuticals, Inc.
1W: +3.6%
1M: -2.0%
3M: -8.6%
YTD: -28.4%
1Y: -42.6%
3Y: +0.7%
5Y: -69.0%
$7.94
-0.29 (-3.52%)
Weekly Expected Move ±8.3%
$6
$7
$7
$8
$9
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$99M
Revenue
+1.9% YoY
$-198M
Net Income
-1165.0% YoY
$-175M
Free Cash Flow
-732.7% YoY
72.3%
Gross Margin
-265.2%
Op. Margin
-267.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-106.7%
ROA-58.3%
ROIC473.6%
Valuation
P/E-4.0
P/B12.9
EV/EBITDA-3.3
Leverage
Debt/Equity0.85
Current Ratio7.28
Interest Cov.-81.0x
Quality Scores
Piotroski F3/9
Altman Z0.19
Beneish M-0.68